Cancer screening test
The test screens for cancer using a few drops of blood.
Source: LinkedIn company description · Retrieved October 13, 2026
Established in 2001 at Seoul National University Cancer Research Institute, Bioinfra has dedicated more than 15 years to research on in vitro cancer screening technology. The company reports that its test correctly identified more cancer and non-cancer blood samples than a blood-based, single tumor marker test.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Bioinfra provides service to physicians and the medical community.
The test screens for cancer using a few drops of blood.
Source: LinkedIn company description · Retrieved October 13, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text. Source evidence was prepared for review on October 28, 2026. Directory positions use company-contact counts from separately saved list snapshots. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.